Gilead begins testing inhalable form of remdisivir for coronavirus

The company said the trial, which will enroll about 60 healthy Americans aged between 18 and 45, will test the drug particularly in those cases where the disease has not progressed to require hospitalization. (https://bit.ly/38G3Zup)